Health systems chase ROI, target efficiency in AI for 2025
More than 40% of C-suite executives polled by Deloitte said they’ve seen a moderate to significant return on their artificial intelligence investments, but nearly as many said it’s still too early to determine the technology’s full impact.
More than 40% of C-suite executives polled by Deloitte said they’ve seen a moderate to significant return on their artificial intelligence investments, but nearly as many said it’s still too early to determine the technology’s full impact.
Go to Source
2025-02-11 03:21
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.
